Bee sting in most situations is life threatening. Spectrum of bee sting ranges from mild local reaction to death. The literature regarding the bee sting disease from India is sparse. The rare manifestations of the disease include encephalitis, polyneuritis, myocardial infarction, pulmonary edema, bleeding manifestations, and renal failure. Bee sting infections are rare and no field studies have been performed to determine the exact sequence of events that lead to infection of bee stings and if not treated properly can lead to fatal outcomes. Here we present a case of unusual bilateral empyema associated with bee sting.
BACKGROUND Pulmonary tuberculosis (PTB) still remains a global public health problem. Diabetes along with poor glycaemic control leads to an immune compromised state. Type 2 diabetes (DM) is a strong risk factor for tuberculosis (TB) and is associated with a slower response to TB treatment and a higher mortality rate. Objective of the study was to determine the prevalence of rifampicin resistance in pulmonary tuberculosis in patients with DM. METHODS The study was conducted in General Medicine Department, Dr. B.R. Ambedkar Medical College, Bengaluru, Karnataka, from July 2018 to December 2019. Sputum was collected from a total of 100 patients who were sputum smear positive for acid fast bacilli (AFB). Sample was collected and was subjected to GeneXpert testing for the evaluation of resistance against rifampicin. RESULTS In our study the incidence of rifampicin resistance was 45.16 % in diabetes and 5.79 % in non-diabetes which was statistically significant ( 2 -1.1; p-0.01) between rifampicin resistance and diabetic patients’ status with active TB in South Karnataka, India. This result supports previous research showing a higher multidrug-resistant tuberculosis risk in tuberculosis & diabetes patients relative to those with no diabetes. Additionally, correlation of other findings between type 2 diabetes & multidrug-resistant tuberculosis as well as delayed time to sputum smear conversion were confirmed. CONCLUSIONS The results showed correlation between diabetes & rifampicin resistance and probably suggest the necessity of integrated diabetes and tuberculosis surveillance programs in South Karnataka, India. KEYWORDS Rifampicin, Tuberculosis, Diabetes Mellitus
BACKGROUND AND OBJECTIVESDiabetes Mellitus is the commonest metabolic disorder affecting the people all over the world. Diabetic nephropathy is one of the common complications. The relationship between dyslipidaemia and microalbuminuria is of special interest in Indian population on account of significant insulin resistance, which may be the common link between microalbuminuria and dyslipidaemia. This study was conducted to study the lipid profile in micro and normoalbuminuric type 2 diabetics.
BACKGROUND AND OBJECTIVESStroke is one of the most common causes of death worldwide. People who suffer cerebrovascular accidents also have an abnormality in the hearts electrical cycle are at a higher risk of death with 90 days than people who do not have abnormal electrical activity. The ECG changes have been reported predominately with subarachnoid haemorrhage and intracerebral haemorrhage and in a few percentage of cases of cerebral infarct. Present study is an attempt to study the pattern ECG abnormalities in patients with cerebrovascular accidents and its prognostic significance.
BACKGROUNDDengue is a viral disease which is acquired through mosquito bites. It is spread over 128 countries globally. Bleeding is one of the complications of Dengue.Objectives-This study was designed to find the prevalence and type of bleeding in correlation with the platelet count in Dengue.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.